NeuroOne Medical Technologies To Restate Q1 2026 Financial Statements; Restatement Corrects $0.5M Revenue Overstatement For Q1 2026; Net Loss Understated By $0.3M For Q1 2026; Restatement Does Not Affect Fy2026 Product Revenue Guidance Or Cash Position
NeuroOne Medical Technologies Corp NMTC
$3.82
▲ +2.41%
(+$0.09)
Open
$3.75
Prev Close
$3.73
Day Range
$3.66 – $4.05
52W Range
$3.27 – $6.96
Market Cap
$32.15M
Beta
0.56
EPS (TTM)
$-0.62
📋 Company Profile
| Industry | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2012-11-09 |
| Shares Out. | 8,620,000 |
| Website | nmtc1.com/ ↗ |
| Phone | 19524261383 |
NeuroOne Medical Technologies Corp is a publicly traded company under the ticker symbol NMTC on the NASDAQ NMS - GLOBAL MARKET, operating in the Health Care industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
9 analysts (2026-05-01)